Background Recent epidemiological studies have suggested that exposure to c
ertain viruses and bacteria influences the development of allergy and aller
gic diseases, such as asthma. However, there is a paucity of experimental e
vidence examining the consequences of concurrent exposure to allergen and i
nfectious agents, and the potential mechanisms by which allergic disease mi
ght be averted as a result.
Objective To model this situation experimentally, we investigated whether a
virally induced immune response, elicited by a replication-deficient human
type 5 adenovirus (RDA) administered at a site distant from the airways, c
ould inhibit ovalbumin (OVA)-induced airways eosinophilic inflammation.
Methods C57BL/6 mice were infected intramuscularly with RDA 16 h prior to i
ntraperitoneal OVA sensitization. Cellular and cytokine responses in the lu
ng/airways were examined after an OVA aerosol challenge.
Results RDA infection significantly inhibited the inflammatory response in
the lung tissue after antigen challenge. In the bronchoalveolar lavage (BAL
), total cell number, eosinophils and lymphocytes were decreased by 70, 85
and 65%, respectively, after antigen challenge in RDA-treated, compared wit
h untreated, mice. RDA infection had no effect on IgE synthesis. The levels
of IL-5, IL-4 and IFN gamma in the BAL after antigen challenge were signif
icantly lower in RDA-treated mice. In vitro production of cytokines by sple
nocytes in response to OVA restimulation revealed a shift from IL-4 in sens
itized, PBS-treated mice, to IFN gamma in sensitized mice treated with RDA.
Flow cytometric analysis revealed that RDA infection increased the proport
ion of CD8 T cells in the BAL; this change in T-cell subsets was accompanie
d by an increase in both CD4 and CD8 T cells positive for intracellular IFN
gamma. Inhibition of antigen-induced airways inflammation was IFN gamma-de
pendent but did not require IL-12, as RDA-treatment inhibited airways infla
mmation in IL-12 but not IFN gamma knock-out mice.
Conclusion This study demonstrates that an immune response against a replic
ation-deficient adenovirus during the initial exposure to OVA inhibits the
development of airways inflammation after antigen aerosol challenge.